Dr. Tiina Kähkönen is a Study Director of preclinical oncology research at Pharmatest Services Ltd. Kähkönen graduated from University of Turku, Finland, in 2012 majoring in Drug Discovery and Pharmacology. After graduation, she conducted her doctoral thesis work on breast cancer research with a special interest in bone metastasis.Pharmatest Services Ltd is a preclinical CRO specialized in oncology and skeletal disease models. In almost twenty years’ time, Pharmatest has established the proof-of-efficacy for many cancer drug candidates with clinically predictive cell culture assays, orthotopic animal models, and disseminated cancer models. For more information, see www.pharmatest.com.
© 2020 Taconic Biosciences, Inc. All rights reserved.